Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedPubMed data source text was updated to indicate that publications are automatically filled from PubMed. The page revision version was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check29 days agoChange DetectedRemoved the site-wide funding/operating-status notice from the page. The funding lapse and NIH operating-status message no longer appears on the study record.SummaryDifference0.2%

- Check50 days agoChange DetectedA new publication citation (Simpson et al., Dermatology Therapy, 2025) was added under Publications, and the earlier 'Online ahead of print' citation was removed.SummaryDifference0.2%

- Check72 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference1%

- Check79 days agoChange DetectedAdds a new research citation on atopic dermatitis and updates the page to v3.1.0, replacing v3.0.2.SummaryDifference1.0%

- Check93 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2, and removed the Back to Top navigation element.SummaryDifference0.1%

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.